Type 1 and type 2 diabetic patients display different patterns of cellular microparticles

Diabetes

Volumn 51, Issue 9, 2002, Pages 2840-2845

  Sabatier, Florence ^a,b   Darmon, Patrice ^c   Hugel, Benedicte ^d   Combes, Valery ^a,b   Sanmarco, Marielle ^b   Velut, Jean Gabriel ^c   Arnoux, Dominique ^b   Charpiot, Phillipe ^a   Freyssinet, Jean Marie ^d   Oliver, Charles ^c   Sampol, Jose ^a,b   Dignat George, Francoise ^a,b  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c HÔPITAL NORD   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPOCORTIN 5; PROCOAGULANT;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CELL VACUOLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICULATE MATTER; PRIORITY JOURNAL; THROMBOCYTE; THROMBOSIS; VASCULAR DISEASE;

EID: 0036724722     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.9.2840     Document Type: Article

References (40)

1. Diabetes mellitus and diabetes-associated vascular disease
2. Evidence of polymorphonuclear neutrophils activation in patients with insulino dependent diabetes
3. Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy
4. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus
5. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD 14 expression
6. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia
7. Diabetes and endothelial dysfunction: A clinical perspective
8. Endothelial dysfunction in diabetes mellitus
9. The association of reduced endothelium relaxing factor: NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus
10. Endothelium-dependent vasodilatation, plasma markers of endothelium function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions
11. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus
12. Platelet procoagulant activity and microvesicle formation: Its putative role in hemostasis and thrombosis
13. Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: A comparison with standard platelet agonists
14. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
15. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia
16. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection
17. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
18. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
19. A new flow cytometry method of platelet-derived microvesicle quantitation in plasma
20. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria
21. Platelet-derived microparticles in patients with arteriosclerosis obliterans: Enhancement of high shear-induced microparticle generation by cytokines
22. Molecular basis for a link between complement and the vascular complications of diabetes
23. Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patients
24. The temporal importance of TNF alpha expression in the development of diabetes
25. Diabetic peripheral neuropathy: Evidence for apoptosis and associated mitochondrial dysfunction
26. Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus
27. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes
28. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy
29. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus
30. Platelet vesiculation in angina treated with coronary angioplasty
31. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
32. Microparticles from patients with multiple organ dysfunction and sepsis support coagulation through multiple mechanisms
33. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: Findings from brain and renal microvascular cell culture and patients with active disease
34. Activated polymorpho-nuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis
35. Neutrophil-endothelial cells modulation in diabetic patients undergoing coronary artery bypass grafting
36. Advanced glycosylation endproducts induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
37. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
38. Interaction of endothelial microparticles with monocytic cells induces tissue factor-dependent procoagulant activity
39. Endothelial cell activation by leukocyte microparticles
40. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNKI signaling pathway